COVID-19 infection in patients with haematological disease - A tertiary centre experience from north India
Mukul Aggarwal(All India Institute of Medical Sciences), Anjan Trikha(All India Institute of Medical Sciences), Mirza Saleem Amjad(All India Institute of Medical Sciences), K. Ganesh(All India Institute of Medical Sciences), Jasmita Dass(Sir Ganga Ram Hospital), Tulika Seth(Manipal Academy of Higher Education), Naveet Wig(All India Institute of Medical Sciences), Rishi Dhawan(All India Institute of Medical Sciences), Mohan Bairwa(All India Institute of Medical Sciences), Akash Khandelwal(Merck KGaA, Darmstadt (Germany)), Pradeep Kumar(All India Institute of Medical Sciences), Richa Agarwal(Baba Raghav Das Medical College), Punit Khanna(Pain and Rehabilitation Medicine), Seema Tyagi(All India Institute of Medical Sciences Raipur), Manoranjan Mahapatra(All India Institute of Medical Sciences), Akhil Kant Singh(Pain and Rehabilitation Medicine), Arul Selvi(All India Institute of Medical Sciences), Kapil Soni(All India Institute of Medical Sciences)
Cited by 2
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198
Autologous stem cell transplantation in refractory Asherman′s syndrome: A novel cell based therapy
|Journal of Human Reproductive Sciences|2014|184
Environmental and occupational determinants of lung cancer
|Translational Lung Cancer Research|2019|171
Recommendations for screening and early detection of common cancers in India
|The Lancet Oncology|2015|125